|
1
|
Gukovskaya AS and Pandol SJ: Cell death
pathways in pancreatitis and pancreatic cancer. Pancreatology.
4:567–586. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tuveson DA and Neoptolemos JP:
Understanding metastasis in pancreatic cancer: a call for new
clinical approaches. Cell. 148:21–23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rasheed ZA, Kowalski J, Smith BD and
Matsui W: Concise review: emerging concepts in clinical targeting
of cancer stem cells. Stem Cells. 29:883–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simeone DM: Pancreatic cancer stem cells:
implications for the treatment of pancreatic cancer. Clin Cancer
Res. 14:5646–5648. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lapidot T, Sirard C, Vormoor J, Murdoch B,
Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and
Dick JE: A cell initiating human acute myeloid leukaemia after
transplantation into SCID mice. Nature. 367:645–648. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Silverman DT, Swanson CA, Gridley G,
Wacholder S, Greenberg RS, Brown LM, Hayes RB, Swanson GM,
Schoenberg JB, Pottern LM, Schwartz AG, Fraumeni JF Jr and Hoover
RN: Dietary and nutritional factors and pancreatic cancer: a
case-control study based on direct interviews. J Natl Cancer Inst.
90:1710–1719. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kirsh VA, Peters U, Mayne ST, Subar AF,
Chatterjee N, Johnson CC and Hayes RB: Prospective study of fruit
and vegetable intake and risk of prostate cancer. J Natl Cancer
Inst. 99:1200–1209. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Zhang W, Sun L, Yu H, Ni QX, Risch
HA and Gao YT: Green tea drinking and risk of pancreatic cancer: a
large-scale, population-based case-control study in urban Shanghai.
Cancer Epidemiol. 36:e354–e358. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Herr I, Lozanovski V, Houben P, Schemmer P
and Buchler MW: Sulforaphane and related mustard oils in focus of
cancer prevention and therapy. Wien Med Wochenschr. 163:80–88.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang CS and Wang H: Cancer therapy
combination: green tea and a phosphodiesterase 5 inhibitor? J Clin
Invest. 123:556–558. 2013.PubMed/NCBI
|
|
13
|
Boots AW, Haenen GR and Bast A: Health
effects of quercetin: from antioxidant to nutraceutical. Eur J
Pharmacol. 585:325–337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kallifatidis G, Rausch V, Baumann B, Apel
A, Beckermann BM, Groth A, Mattern J, Li Z, Kolb A, Moldenhauer G,
Altevogt P, Wirth T, Werner J, Schemmer P, Büchler MW, Salnikov A
and Herr I: Sulforaphane targets pancreatic tumour-initiating cells
by NF-kappaB-induced antiapoptotic signalling. Gut. 58:949–963.
2009. View Article : Google Scholar
|
|
15
|
Rausch V, Liu L, Kallifatidis G, Baumann
B, Mattern J, Gladkich J, Wirth T, Schemmer P, Büchler MW, Zöller
M, Salnikov A and Herr I: Synergistic activity of sorafenib and
sulforaphane abolishes pancreatic cancer stem cell characteristics.
Cancer Res. 70:5004–5013. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kallifatidis G, Labsch S, Rausch V,
Mattern J, Gladkich J, Moldenhauer G, Büchler MW, Salnikov A and
Herr I: Sulforaphane increases drug-mediated cytotoxicity towards
cancer stem-like cells of pancreas and prostate. Mol Ther.
19:188–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Wicha MS, Schwartz SJ and Sun D:
Implications of cancer stem cell theory for cancer chemoprevention
by natural dietary compounds. J Nutr Biochem. 22:799–806. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou W, Kallifatidis G, Baumann B, Rausch
V, Mattern J, Gladkich J, Giese N, Moldenhauer G, Wirth T, Buchler
MW, Salnikov AV and Herr I: Dietary polyphenol quercetin targets
pancreatic cancer stem cells. Int J Oncol. 37:551–561.
2010.PubMed/NCBI
|
|
19
|
Kurbitz C, Heise D, Redmer T, Goumas F,
Arlt A, Lemke J, Rimbach G, Kalthoff H and Trauzold A: Epicatechin
gallate and catechin gallate are superior to epigallocatechin
gallate in growth suppression and anti-inflammatory activities in
pancreatic tumor cells. Cancer Sci. 102:728–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bao B, Ali S, Banerjee S, Wang Z, Logna F,
Azmi AS, Kong D, Ahmad A, Li Y, Padhye S and Sarkar FH: Curcumin
analogue CDF inhibits pancreatic tumor growth by switching on
suppressor microRNAs and attenuating EZH2 expression. Cancer Res.
72:335–345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kong D, Heath E, Chen W, Cher ML, Powell
I, Heilbrun L, Li Y, Ali S, Sethi S, Hassan O, Hwang C, Gupta N,
Chitale D, Sakr WA, Menon M and Sarkar FH: Loss of let-7
up-regulates EZH2 in prostate cancer consistent with the
acquisition of cancer stem cell signatures that are attenuated by
BR-DIM. PLoS One. 7:e337292012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, VandenBoom TG II, Kong D, Wang Z,
Ali S, Philip PA and Sarkar FH: Up-regulation of miR-200 and let-7
by natural agents leads to the reversal of
epithelial-to-mesenchymal transition in gemcitabine-resistant
pancreatic cancer cells. Cancer Res. 69:6704–6712. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
25
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nair VS, Maeda LS and Ioannidis JP:
Clinical outcome prediction by microRNAs in human cancer: a
systematic review. J Natl Cancer Inst. 104:528–540. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ruckert F, Aust D, Bohme I, Werner K,
Brandt A, Diamandis EP, Krautz C, Hering S, Saeger HD, Grutzmann R
and Pilarsky C: Five primary human pancreatic adenocarcinoma cell
lines established by the outgrowth method. J Surg Res. 172:29–39.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nicoletti I, Migliorati G, Pagliacci MC,
Grignani F and Riccardi C: A rapid and simple method for measuring
thymocyte apoptosis by propidium iodide staining and flow
cytometry. J Immunol Methods. 139:271–279. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rausch V, Liu L, Apel A, Rettig T,
Gladkich J, Labsch S, Kallifatidis G, Kaczorowski A, Groth A, Gross
W, Gebhard MM, Schemmer P, Werner J, Salnikov AV, Zentgraf H,
Buchler MW and Herr I: Autophagy mediates survival of pancreatic
tumour-initiating cells in a hypoxic microenvironment. J Pathol.
227:325–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang SN, Fu J, Nall D, Rodova M, Shankar S
and Srivastava RK: Inhibition of sonic hedgehog pathway and
pluripotency maintaining factors regulate human pancreatic cancer
stem cell characteristics. Int J Cancer. 131:30–40. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sipos B, Moser S, Kalthoff H, Torok V,
Lohr M and Kloppel G: A comprehensive characterization of
pancreatic ductal carcinoma cell lines: towards the establishment
of an in vitro research platform. Virchows Arch. 442:444–452.
2003.PubMed/NCBI
|
|
32
|
Liu L, Salnikov AV, Bauer N,
Aleksandrowicz E, Labsch S, Nwaeburu C, Mattern J, Gladkich J,
Schemmer P, Werner J and Herr I: Triptolide reverses
hypoxia-induced EMT and stem-like features in pancreatic cancer by
NF-kappa B downregulation. Int J Cancer. 134:2489–2503. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vistica DT, Skehan P, Scudiero D, Monks A,
Pittman A and Boyd MR: Tetrazolium-based assays for cellular
viability: a critical examination of selected parameters affecting
formazan production. Cancer Res. 51:2515–2520. 1991.PubMed/NCBI
|
|
34
|
Ischenko I, Zhi J, Moll UM, Nemajerova A
and Petrenko O: Direct reprogramming by oncogenic Ras and Myc. Proc
Natl Acad Sci USA. 110:3937–3942. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shankar S, Marsh L and Srivastava RK: EGCG
inhibits growth of human pancreatic tumors orthotopically implanted
in Balb C nude mice through modulation of FKHRL1/FOXO3a and
neuropilin. Mol Cell Biochem. 372:83–94. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Brinker AM, Ma J, Lipsky PE and Raskin I:
Medicinal chemistry and pharmacology of genus
Tripterygium(Celastraceae). Phytochemistry. 68:732–766.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang H, Bian S and Yang CS: Green tea
polyphenol EGCG suppresses lung cancer cell growth through
upregulating miR-210 expression caused by stabilizing HIF-1alpha.
Carcinogenesis. 32:1881–1889. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Arola-Arnal A and Blade C:
Proanthocyanidins modulate microRNA expression in human HepG2
cells. PLoS One. 6:e259822011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Xiao J, Gong AY, Eischeid AN, Chen D, Deng
C, Young CY and Chen XM: miR-141 modulates androgen receptor
transcriptional activity in human prostate cancer cells through
targeting the small heterodimer partner protein. Prostate.
72:1514–1522. 2012. View Article : Google Scholar
|
|
40
|
Shan Y, Zhang L, Bao Y, Li B, He C, Gao M,
Feng X, Xu W, Zhang X and Wang S: Epithelial-mesenchymal
transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail,
ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells. J
Nutr Biochem. 24:1062–1069. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hardy TM and Tollefsbol TO: Epigenetic
diet: impact on the epigenome and cancer. Epigenomics. 3:503–518.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vanden Berghe W: Epigenetic impact of
dietary polyphenols in cancer chemoprevention: lifelong remodeling
of our epigenomes. Pharmacol Res. 65:565–576. 2012.PubMed/NCBI
|
|
43
|
Gerhauser C: Epigenetic impact of dietary
isothiocyanates in cancer chemoprevention. Curr Opin Clin Nutr
Metab Care. 16:405–410. 2013. View Article : Google Scholar : PubMed/NCBI
|
